Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2
Anna Vihola(University of Helsinki), Bjarne Udd(Folkhälsans Forskningscentrum), Jean‐Yves Hogrel(Institut de Myologie), P. Lafôret(Sorbonne Université), Guillaume Bassez(Centre Hospitalier Universitaire Henri-Mondor), G. Meola(IRCCS Policlinico San Donato), S. Zhang(Cancer Genetics (United States)), B. Eymard(University Hospital of Basel), Hannu Haapasalo(Tampere University Hospital), Andrée Rouche(Sorbonne Université), Thierry Maisonobe(Sorbonne Université), Ralf Krahe(University of Helsinki), E. Mancinelli(Cancer Genetics (United States)), J. F. Pellissier, Anders Paetau(Helsinki University Hospital)
Cited by 173
Related Papers
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
|The Lancet Neurology|2012|487
Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin
|The American Journal of Human Genetics|2002|484
Mutations in dynamin 2 cause dominant centronuclear myopathy
|Nature Genetics|2005|462
FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study
|The Lancet Neurology|2011|420